跳至主要内容
临床试验/NCT01058473
NCT01058473已完成不适用

Psychometric Evaluation of the Inpatient Pediatric Physical Activity Questionnaire (IPPAQ) in Pediatric Patients With Sickle Cell Disease Hospitalized With Vasoocclusive Pain

Connecticut Children's Medical Center1 个研究点 分布在 1 个国家目标入组 159 人开始时间: 2010年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
159
试验地点
1
主要终点
IPPAQ

研究概览

简要总结

Historically, sickle cell disease has not been viewed in the chronic pain paradigm because of its recurrent nature. Patients with sickle cell disease may be hospitalized for extended periods of time. As the hospital stay progresses, patients with SCD pain are often observed by clinicians to have improvements in function in areas such as self-care, mobility, and recreation despite continued self-report of high pain scores. This pattern of functional improvement with continued report of high pain intensity scores is common in patients with recurrent and chronic pain. A functional assessment tool that can assess function in the acute inpatient setting is needed.

The purpose of this study is to evaluate the Inpatient Pediatric Physical Activity Questionnaire (IPPAQ), as a measure of daily function in children with sickle cell disease hospitalized with vasoocclusive pain.

详细描述

Refer to Brief Summary

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
7 Years 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Documented sickle cell disease
  • Sudden onset of pain consistent with vasoocclusive episode at the time of hospitalization.
  • Pain requiring hospitalization and placement on standard clinical guideline for management of acute pain in sickle cell disease during hospitalization
  • Cognitive ability to report pain on a 0-10 Numerical Rating Scale (NRS)
  • Parental/patient consent and child assent

排除标准

  • Primary diagnosis other than vasoocclusive pain
  • Concurrent Acute Chest Syndrome (ACS)
  • Patient previously enrolled in this study
  • Inability to understand English

结局指标

主要结局

IPPAQ

时间窗: 1 day

This is a functional assessment tool for pediatric sickle cell patients that is admisistered once a day.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

William Zempsky, MD

Director, Pain Relief Program

Connecticut Children's Medical Center

研究点 (1)

Loading locations...

相似试验

Psychometric Evaluation of the IPPAQ in Pediatric... | 临床试验